ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 68 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $23,292 | +158.8% | 25,181 | +1042.5% | 0.00% | – |
| Q2 2019 | $9,000 | +125.0% | 2,204 | +169.1% | 0.00% | – |
| Q1 2019 | $4,000 | -20.0% | 819 | -10.7% | 0.00% | – |
| Q4 2018 | $5,000 | -99.3% | 917 | -98.3% | 0.00% | -100.0% |
| Q3 2018 | $715,000 | +13.9% | 52,759 | -0.3% | 0.04% | +5.0% |
| Q2 2018 | $628,000 | -43.9% | 52,898 | -46.9% | 0.04% | -50.6% |
| Q1 2018 | $1,120,000 | +185.0% | 99,694 | +69.4% | 0.08% | +153.1% |
| Q4 2017 | $393,000 | +7.7% | 58,853 | +32.1% | 0.03% | -3.0% |
| Q3 2017 | $365,000 | -17.2% | 44,559 | -54.6% | 0.03% | -21.4% |
| Q2 2017 | $441,000 | +312.1% | 98,183 | +403.3% | 0.04% | +320.0% |
| Q1 2017 | $107,000 | -47.0% | 19,506 | -21.7% | 0.01% | -64.3% |
| Q1 2016 | $202,000 | – | 24,900 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $5,165,000 | 4.93% |
| Long Focus Capital Management, LLC | 4,429,491 | $9,125,000 | 1.17% |
| Endurant Capital Management LP | 2,160,890 | $4,451,000 | 1.17% |
| NEA Management Company, LLC | 17,082,611 | $35,190,000 | 1.02% |
| Matrix Capital Management Company, LP | 38,974,185 | $80,287,000 | 0.96% |
| Key Client Fiduciary Advisors, LLC | 420,447 | $866,000 | 0.68% |
| ACT CAPITAL MANAGEMENT, LLC | 90,000 | $185,000 | 0.20% |
| DAFNA Capital Management LLC | 351,064 | $723,000 | 0.19% |
| PFM Health Sciences, LP | 2,374,674 | $4,892,000 | 0.18% |
| Rock Springs Capital Management LP | 2,297,194 | $4,732,000 | 0.12% |